For example, GLP-1R agonists were able to improve glucose metabolism function through the GLP-1R/SIRT1/GLUT4 pathway in an AD model (Figure 2), suggesting that GLP-1R may be a key factor linking these two diseases
Theres no official meal plan attached to these medications, but there is a consistent, well-documented pattern in how clinicians and dietitians guide patients through eating less while still eating well
If the drug passes CDER evaluation, it receives FDA approval
Semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, has emerged as the commercial powerhouse, with the oral version launching in January 2026 following December 2025 FDA approval [3]
Adequate sleep, proper nutrition, and B12 supplementation may help